Published in Am J Hyg on January 01, 1963
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus. Clin Cancer Res (2008) 1.91
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin Cancer Res (2012) 1.67
REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer. Clin Cancer Res (2010) 1.53
Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics. Cytokine Growth Factor Rev (2010) 1.46
Tumor infection by oncolytic reovirus primes adaptive antitumor immunity. Clin Cancer Res (2008) 1.44
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors. Invest New Drugs (2009) 1.41
Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers. Clin Cancer Res (2010) 1.35
Respiratory virus antibodies in human sera from different regions of the world. Bull World Health Organ (1965) 1.31
REOVIRUS ENCEPHALITIS IN NEWBORN MICE: AN ELECTRON MICROSCOPIC AND VIRUS ASSAY STUDY. Am J Pathol (1965) 1.26
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma. Mol Ther (2012) 1.20
Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2. Clin Cancer Res (2009) 1.17
Reovirus as a novel oncolytic agent. J Clin Invest (2000) 1.11
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer (2012) 1.09
Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. Gene Ther (2012) 1.08
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors. Invest New Drugs (2012) 1.02
Oncolytic viruses: From bench to bedside with a focus on safety. Hum Vaccin Immunother (2015) 1.01
A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma. Clin Cancer Res (2014) 0.91
Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors. Clin Cancer Res (2014) 0.87
A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report. Pediatr Blood Cancer (2015) 0.81
Reovirus-associated meningoencephalomyelitis in baboons. Vet Pathol (2013) 0.80
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm. J Exp Clin Cancer Res (2014) 0.80
Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants. Viruses (2015) 0.78
The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies. Biomedicines (2017) 0.78
The oncolytic effects of reovirus in canine solid tumor cell lines. J Vet Med Sci (2015) 0.77
Respiratory infection of mice with mammalian reoviruses causes systemic infection with age and strain dependent pneumonia and encephalitis. Virol J (2013) 0.77
Reovirus serotypes elicit distinctive patterns of recall immunity in humans. J Virol (2008) 0.76
Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value. Am Soc Clin Oncol Educ Book (2015) 0.75
Colorectal clinical trials: what is on the horizon? Future Oncol (2016) 0.75
Naturally occurring reoviruses for human cancer therapy. BMB Rep (2015) 0.75
UNDERSTANDING OF VIRAL RESPIRATORY ILLNESSES PROVIDED BY EXPERIMENTS IN VOLUNTEERS. Bacteriol Rev (1964) 0.75
Hemagglutination and hemagglutination-inhibition with measles virus. Virology (1961) 3.88
A hemagglutination-inhibition technique for typing adenoviruses. Am J Hyg (1960) 3.73
Serologic grouping of reoviruses by hemagglutination-inhibition. Am J Hyg (1960) 2.89
DIAGNOSTIC AND PROGNOSTIC VALUE OF CLINICAL AND LABORATORY FINDINGS IN CRYPTOCOCCAL MENINGITIS, A FOLLOW-UP STUDY OF FORTY PATIENTS. N Engl J Med (1964) 2.08
Reoviruses in animals other than man. Ann N Y Acad Sci (1962) 2.05
Observations on a newly recognized virus (Abney) of the reovirus family. Am J Hyg (1960) 1.86
Eosinophilic meningoencephalitis caused by a metastrongylid lung-worm of rats. JAMA (1962) 1.81
The improved prognosis of cryptococcal meningitis with amphotericin B therapy. Ann Intern Med (1963) 1.58
Natural and experimental infection of catle with human types of reoviruses. Am J Hyg (1960) 1.53
Patterns of measles antibodies in residents of Tahiti and their stability in the absence of re-exposure. J Immunol (1962) 1.48
Acute respiratory disease in normal volunteers associated with Coxsackie A-21 viral infection. III. Response to nasopharyngeal and enteric inoculation. J Clin Invest (1963) 1.44
The transmission of dengue by Aedes polynesiensis Marks. Am J Trop Med Hyg (1954) 1.38
Homologous and heterologous complement fixing antibody in persons infected with ECHO; Coxsackie and poliomyelitis viruses. Proc Soc Exp Biol Med (1959) 1.36
Poliomyelitis in French Oceania; epidemiologic observations on an outbreak with notes on the incidence of paralysis following intramuscular injections. Am J Hyg (1953) 1.31
FACTORS AFFECTING HEMAGGLUTINATION BY ENTEROVIRUSES. Proc Soc Exp Biol Med (1964) 1.25
Metabolism of dl-adrenaline-2-C14 in the human. Proc Soc Exp Biol Med (1958) 1.24
Respiratory illness in six infants infected with a newly recognized ECHO virus. Pediatrics (1958) 1.20
CLINICAL AND LABORATORY OBSERVATIONS ON TYPE E BOTULISM IN MAN. Medicine (Baltimore) (1964) 1.19
TOLUCA-3, A NEWLY RECOGNIZED ENTEROVIRUS. Proc Soc Exp Biol Med (1965) 1.19
Metabolism of noradrenaline in the human. J Clin Invest (1959) 1.18
Picornaviruses: classification of nine new types. Science (1963) 1.17
Further observation on typing adenoviruses and a description of two possible additional serotypes. Proc Soc Exp Biol Med (1962) 1.17
Further observations on the natural infection of cattle with reoviruses. Am J Hyg (1963) 1.15
MEMORANDUM ON THE FIRST REPORT OF ANGIOSTRONGYLUS IN MAN, BY NOMURA AND LIN, 1945. Am J Trop Med Hyg (1964) 1.14
Hemagglutination by adenoviruses. Virology (1958) 1.11
Four newly recognized adenoviruses. Proc Soc Exp Biol Med (1961) 1.09
Experimental infection of New World monkeys with dengue and yellow fever viruses. Am J Trop Med Hyg (1958) 1.06
Acute respiratory diseases of viral etiology. II. Adenoviruses. Am J Public Health Nations Health (1962) 1.04
Observations on a newly recognized ECHO virus and a description of an outbreak in a nursery. Am J Hyg (1958) 1.03
Hemagglutination and hemagglutination-inhibition with Coxsackie B viruses. Proc Soc Exp Biol Med (1961) 1.01
Hemagglutination by Coe virus. Virology (1961) 1.00
STUDIES IN VOLUNTEERS WITH RESPIRATORY VIRAL AGENTS: SMALL PARTICLE AEROSOL; HETEROTYPIC PROTECTION; VIRAL CHEMOTHERAPY; BOVINE REOVIRUS IN MAN. Am Rev Respir Dis (1963) 0.99
Observations on an outbreak of eosinophilic meningitis on Tahiti, French Polynesia. Am J Hyg (1961) 0.98
Typing of ECHO viruses by a complement fixation technic. Proc Soc Exp Biol Med (1958) 0.97
Morphologic variations of larvae of the scutellaris group of Aedes (Diptera, Culicidae) in Polynesia. Am J Trop Med Hyg (1954) 0.94
Observations on the epidemilogy of dengue in Panama. Am J Hyg (1958) 0.94
Observations on some little-known adenoviruses. Proc Soc Exp Biol Med (1962) 0.93
Hemagglutination-inhibition antibody responses in human adenovirus infections. Proc Soc Exp Biol Med (1961) 0.88
ANGIOSTRONGYLUS CANTONENSIS INFECTION IN RATS AND RHESUS MONKEYS, AND OBSERVATIONS ON THE SURVIVAL OF THE PARASITE IN VITRO. Am J Trop Med Hyg (1963) 0.88
ON THE ALLEGED ANTIGENIC RELATION BETWEEN ECHO VIRUS TYPES 29 AND 32. Proc Soc Exp Biol Med (1965) 0.86
Identification of a cytopathogenic agent called U-virus recovered from patients with non-diphtheritic croup and from day-nursery children. Arch Gesamte Virusforsch (1959) 0.83
Infantile disseminated histoplasmosis. A case reporting pillow feathers as a source of infection. JAMA (1962) 0.82
Attenuated measles-virus vaccine. Clinical, antigenic, and prophylactic effects when administered with gamma globulin. JAMA (1962) 0.82
STUDIES ON EOSINOPHILIC MENINGITIS. I. OBSERVATIONS ON THE GEOGRAPHIC DISTRIBUTION OF ANGIOSTRONGYLUS CANTONENSIS IN THE PACIFIC AREA AND ITS PREVALENCE IN WILD RATS. Am J Epidemiol (1965) 0.81
Studies on avian malaria in vectors and hosts of encephalitis in Kern County, California. II. Infections in mosquito vectors. Am J Trop Med Hyg (1954) 0.81
The effect of iproniazid on the metabolism of dl-epinephrine-2-C14 in the human. J Pharmacol Exp Ther (1959) 0.80
Acute cerebellar ataxia in children associated with infection by poliovirus I. Pediatrics (1962) 0.80
GOODALL M: Identification of vanillic acid as a catabolite of noradrenaline metabolism in the human. Proc Soc Exp Biol Med (1962) 0.79
SUBCLASSIFICATION OF PICORNAVIRUSES. Bacteriol Rev (1965) 0.79
Structural changes in pulmonary arteries in first year of life. AMA Arch Pathol (1957) 0.79
OBSERVATIONS ON A GROUP OF VIRUSES (JV-5, JV-6 AND JV-10) COMPRISING A NEWLY RECOGNIZED ENTEROVIRUS SEROTYPE. Am J Hyg (1964) 0.79
OBSERVATIONS ON AN OUTBREAK OF INFECTION WITH A NEWLY RECOGNIZED ENTEROVIRUS (JV-4). Am J Hyg (1964) 0.78
The craniovertebral veins and sinuses of the dog. Am J Anat (1962) 0.77
Studies on avian malaria in vectors and hosts of encephalitis in Kern County, California. III. The comparative vector ability of some of the local culicine mosquitoes. Am J Trop Med Hyg (1954) 0.77
The correlation of brain pattern and feeding habits in four species of cyprinid fishes. J Comp Neurol (1952) 0.76
[Respiratory enterovirus and reovirus infections]. Arch Gesamte Virusforsch (1963) 0.76
Effect of iproniazid on metabolism of noradrenaline in man. Am J Physiol (1962) 0.76
Conjunctivitis and enteric infection with adenovirus types 26 and 27: responses to primary, secondary and reciprocal cross-challenges. Am J Hyg (1963) 0.76
Infection of human volunteers with a reovirus of bovine origin. Proc Soc Exp Biol Med (1963) 0.76
URINARY EXCRETION OF NORADRENALINE AND ITS METABOLITES AT TEN-MINUTE INTERVALS AFTER INTRAVENOUS INJECTION OF DL-NORADRENALINE-2-C. J Clin Invest (1963) 0.75
ECHO VIRUS TYPE 25, INFECTION IN ADULT VOLUNTEERS. Proc Soc Exp Biol Med (1965) 0.75
Ecology of a newly recognized common respiratory agent RS virus. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1961) 0.75
Selected aspects in the development of the mother's understanding of her mentally retarded child. Am J Ment Defic (1954) 0.75
Unusual facial granulomas occurring in a child. Report of a case. Arch Dermatol (1961) 0.75
CLINICAL AND LABORATORY MANIFESTATIONS OF TYPE E BOTULISM IN MAN. Trans Assoc Am Physicians (1964) 0.75
ECHO VIRUS TYPE I AND ASEPTIC MENINGITIS. REPORT OF A CASE WITH VIRUS ISOLATION FROM THE CEREBROSPINAL FLUID. J Pediatr (1963) 0.75
Periodic fever associated with increased plasma unconjugated etiocholanolone and granulomatous liver disease: case report and studies in etiocholanolone and cortisol conjugation. J Clin Endocrinol Metab (1963) 0.75
[A method of macular stimulation]. Ophthalmologica (1956) 0.75
TECHNOLOGY FOR RAPID IDENTIFICATION OF VIRUS ISOLATES. Am Rev Respir Dis (1963) 0.75
NORMETADRENALINE METABOLISM IN MAN. Biochem Pharmacol (1964) 0.75
THE PROPERTIES OF ENZYME-ACTIVATING COLLOIDS. Ann Histochim (1964) 0.75
FURTHER ATTEMPTS TO INFLUENCE THE ELIMINATION OF RADIOSTRONTIUM. Acta Radiol Ther Phys Biol (1963) 0.75
The incidence and location of metacercarial cysts (Trematoda: Strigeida) on 35 species of Central New York fishes. J Parasitol (1958) 0.75
Observations on Dirofilaria immitis in French Oceania. Ann Trop Med Parasitol (1954) 0.75
Dengue antibodies in residents of the Society Islands, French Ocenia. Am J Trop Med Hyg (1958) 0.75
AN OUTBREAK OF INFECTION WITH ECHO VIRUS TYPE 3 ASSOCIATED WITH A MILD FEBRILE ILLNESS. Am J Hyg (1964) 0.75
[Clinical aspects of a poliomyelitis epidemic in French Oceania; significance of intramuscular injections in the etiology of paralysis]. Presse Med (1952) 0.75
Measles on Tahiti. Am J Dis Child (1962) 0.75
Instrumentation for nuclear studies with externally focused deuteron beam from ten-Mev cyclotron. Rev Sci Instrum (1949) 0.75
Human filariasis in the Marquesas Islands. Am J Trop Med Hyg (1954) 0.75
MULTIPLE MYELOMA. Am J Med (1964) 0.75
Hyoid muscle anomalies in the dog (Canis familiaris). Anat Rec (1959) 0.75
[The use of pantothenic acid in ophthalmology]. Ophthalmologica (1950) 0.75
[Not Available]. Ophthalmologica (1946) 0.75
Conjunctivitis and enteric infection with adenovirus types 26 and 27: responses to primary, secondary and reciprocal cross-challenges. Trans Assoc Am Physicians (1962) 0.75
ANGIOGRAPHIC VISUALIZATION OF THE SUBARACHNOID CISTERNS. Radiology (1965) 0.75
PIONEERING IN A NEW WORLD. J Am Osteopath Assoc (1965) 0.75